Picture of ANI Pharmaceuticals logo

ANIP ANI Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

HubSpot rises after Barclays upgrades to 'overweight' on AI capabilities

** Shares of online marketing software provider HubSpot HUBS.N rise 3.7% to $612.27

** Brokerage Barclays upgrades to "overweight" from "equal weight"; PT remains unchanged at $815, a 34% upside to the stock's last close

** Says that HUBS' cohesive system of record and AI-powered features stands apart against its competitors

** "We think HUBS' new pricing model could help the company better monetize free users within existing customers, as users must pay for the ability to edit within HubSpot" - Brokerage

** Stock down 3.5% in the past 12 months

 (Reporting by Padmanabhan Ananthan)

 ((Padmanabhan.Ananthan@thomsonreuters.com;))

Recent news on ANI Pharmaceuticals

See all news